Cheryl A. Frye

ORCID: 0000-0002-8452-296X · 8 papers in corpus · active 2000-2014

Study types

  • article 8
article 2014
Role of pregnane xenobiotic receptor in the midbrain ventral tegmental area for estradiol- and 3α,5α-THP-facilitated lordosis of female rats
·doi:10.1007/s00213-013-3406-0
article 2008
Activity of protein kinase C is important for 3α,5α-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats
·doi:10.1016/j.brainresbull.2008.07.002
article 2008
Effects of manipulating progesterone and NMDA receptors in the ventral tegmental area for lordosis of hamsters and rats
·doi:10.1007/s00213-008-1143-6
article 2006
In the Ventral Tegmental Area, Progestins’ Membrane-Mediated Actions for Lordosis of Hamsters and Rats Involve Protein Kinase A
·doi:10.1159/000100510

Progestin-facilitated lordosis of hamsters and rats is enhanced by activation of dopamine type 1 (D1) or GABAA/benzodiazepine receptor complexes (GBRs) in the ventral tegmental area (VTA) and these effects involve G-proteins and second mess…

article 2004
Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors
·doi:10.1016/j.pbb.2004.04.014
article 2003
3Vα,5α-THP’s Actions in the entral Tegmental Area for Lordosis: A Model System for Defining Mechanisms and Function of Progestins
·doi:10.1201/9780203508169-17
article 2003
Fluoxetine May Influence Lordosis of Rats through Effects on Midbrain 3α,5α‐THP Concentrations
·doi:10.1196/annals.1286.004

5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) in the ventral tegmental area (VTA) mediates lordosis of rodents. If fluoxetine's effects on lordosis are mediated in part by midbrain 3alpha,5alpha-THP, then fluoxetine regimens that decr…

article 2000
Intravenous progesterone elicits a more rapid induction of lordosis in rats than does SKF38393
·doi:10.3758/bf03330633

In ovariectomized (ovx), estradiol (E)-primed rats, progesterone (P) facilitates sexual receptivity within 2–30 min following intravenous (i.v.) administration. Intracerebroventricular infusion of P or the dopamine receptor type 1-like (D1)…